Page last updated: 2024-10-30

vitamin k 3 and Acute Lung Injury

vitamin k 3 has been researched along with Acute Lung Injury in 1 studies

Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, S1
Nishiumi, S1
Nishida, M1
Mizushina, Y1
Kobayashi, K1
Masuda, A1
Fujita, T1
Morita, Y1
Mizuno, S1
Kutsumi, H1
Azuma, T1
Yoshida, M1

Other Studies

1 other study available for vitamin k 3 and Acute Lung Injury

ArticleYear
Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-kappaB activation.
    Clinical and experimental immunology, 2010, Volume: 160, Issue:2

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; C

2010